PSTV stock

Plus Therapeutics Inc (PSTV) receives a Buy rating from D. Boral Capital
Anna Perez
Plus Therapeutics Inc’s filing revealed that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for reported ...

Plus Therapeutics Inc (PSTV) rating upgrades by D. Boral Capital
Anna Perez
In a filing, Plus Therapeutics Inc revealed its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...

An Analysis of Plus Therapeutics Inc (PSTV)’s Potential Price Growth
Samantha Gray
In a filing, Plus Therapeutics Inc revealed its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...

Investing in Plus Therapeutics Inc (PSTV): What You Must Know
Anna Perez
Plus Therapeutics Inc’s filing revealed that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for reported ...

Plus Therapeutics Inc’s latest rating changes from various analysts
Jaxson Clark
In a filing, Plus Therapeutics Inc revealed its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...





